Status:
RECRUITING
Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
Lead Sponsor:
Utah Eye Centers
Conditions:
Correction Vision Surgery
Cataract Surgery
Eligibility:
All Genders
Brief Summary
Millions of people have undergone laser vision correction surgery and are motivated to continue with spectacle independence as they develop presbyopia (gradual loss of your eyes' ability to focus on n...
Eligibility Criteria
Inclusion
- o Bilateral age-related visually significant cataracts in otherwise healthy eyes, undergoing uncomplicated bilateral sequential Clareon Vivity IOLs
- Prior history of uncomplicated post-refractive myopic surgery (LASIK/PRK) with up to 1 enhancement treatment
- Potential acuity measured post-operatively 20/25 or better in both eyes
- Patients with regular astigmatism that can be managed with T3 toric lens or arcuate incision
Exclusion
- o Ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, etc.
- Prior ocular surgeries other than uncomplicated corneal refractive surgery and excluding RK
- Patients with irregular astigmatism/topography (to rule out signs of potential ectasia), corneal dystrophies, and pupil abnormalities
- Total HOA cutoff of ≤0.5, coma ≤0.3
- RLE patients
Key Trial Info
Start Date :
January 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06924944
Start Date
January 20 2025
End Date
April 1 2026
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Utah Eye Centers
Ogden, Utah, United States, 84403